Form EFFECT Silexion Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 18, 2026 9:00 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BXP Announces Second Quarter 2026 Results
- Western New England Bancorp, Inc. Reports Results for Three and Six Months Ended June 30, 2026 and Declares Quarterly Cash Dividend
- Rush Enterprises, Inc. Reports Second Quarter 2026 Results, Announces Three-For-Two Stock Split and $0.14 Per Share Dividend (Post-Stock Split)
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
